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Abstract
Introduction: High-fat diets (HFDs) are known to cause obesity and are associated with breast cancer progression
and metastasis. Because obesity is associated with breast cancer progression, it is important to determine whether
dietary fat per se stimulates breast cancer progression in the absence of obesity. This study investigated whether an
HFD increases breast cancer growth and metastasis, as well as mortality, in obesity-resistant BALB/c mice.
Methods: The 4-week-old, female BALB/c mice were fed HFD (60% kcal fat) or control diet (CD, 10% kcal fat) for
16 weeks. Subsequently, 4T1 mammary carcinoma cells were injected into the inguinal mammary fat pads of mice
fed continuously on their respective diets. Cell-cycle progression, angiogenesis, and immune cells in tumor tissues,
proteases and adhesion molecules in the lungs, and serum cytokine levels were analyzed with
immunohistochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA). In vitro studies were
also conducted to evaluate the effects of cytokines on 4T1 cell viability, migration, and adhesion.
Results: Spleen and gonadal fat-pad weights, tumor weight, the number and volume of tumor nodules in the
lung and liver, and tumor-associated mortality were increased in the HFD group, with only slight increases in
energy intake and body weight. HF feeding increased macrophage infiltration into adipose tissues, the number of
lipid vacuoles and the expression of cyclin-dependent kinase (CDK)2, cyclin D1, cyclin A, Ki67, CD31, CD45, and
CD68 in the tumor tissues, and elevated serum levels of complement fragment 5a (C5a), interleukin (IL)-16,
macrophage colony-stimulating factor (M-CSF), soluble intercellular adhesion molecule (sICAM)-1, tissue inhibitors
of metalloproteinase (TIMP)-1, leptin, and triggering receptor expressed on myeloid cells (TREM)-1. Protein levels of
the urokinase-type plasminogen activator, ICAM-1, and vascular cell adhesion molecule-1 were increased, but
plasminogen activator inhibitor-1 levels were decreased in the lungs of the HFD group. In vitro assays using 4T1
cells showed that sICAM-1 increased viability; TREM-1, TIMP-1, M-CSF, and sICAM-1 increased migration; and C5a,
sICAM-1, IL-16, M-CSF, TIMP-1, and TREM-1 increased adhesion.
Conclusions: Dietary fat increases mammary tumor growth and metastasis, thereby increasing mortality in obesity-
resistant mice.
Introduction
Breast cancer is a leading cause of cancer-associated
mortality in women in the United States [1], and the
incidence is increasing in the developing world. The
majority of breast cancer-related death results from
uncontrolled metastatic disease. Although in 10% to
15% of cases, breast cancer spreads to other parts of the
body within 3 years of initial diagnosis, metastasis tends
to recur later, 10 years or more after the detection of
the primary tumor [2]. However, current therapies
including surgery, hormone therapy, chemotherapy,
radiation therapy, and selective combinations thereof are
not completely effective in the treatment of metastatic
breast cancer [3]. Thus, it is important to find safe and
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any medium, provided the original work is properly cited.effective lifestyle modifications, including dietary habits,
for decreasing breast cancer development and
metastasis.
Epidemiologic studies indicate that consuming a high-
fat (regardless of fat type) diet may lead to an increased
risk of invasive breast cancer in postmenopausal women
[4]. High-fat diets are known to induce obesity in
humans and rodents [5,6], and obese women have an
increased risk of developing postmenopausal breast can-
cer [7,8]. Additionally, a high body mass index (BMI) is
associated with poor prognosis in breast cancer patients
[9,10]. Thus, it is clearly important to understand the
molecular basis for the association of high-fat diet and/or
obesity with breast cancer development and mortality.
In 1991 Rose et al. [11] reported that a diet containing
2 3 %a so p p o s e dt o5 %( w t / w t )c o r no i l( r i c hi nt h e
omega-6 fatty acid linoleic acid) increased the tumor
growth rate and lung-metastasis incidence of MDA-MB-
435 human breast cancer cells injected into the mam-
mary fat pads of athymic nude mice. To evaluate the
effects of a high-fat diet on cancer development and
progression and the underlying mechanisms thereof, we
used the 4T1 orthotopic model, in which 4T1 mammary
carcinoma cells are injected into the mammary fat pads
of immune-competent BALB/c mice. The 4T1 cells
were derived from the mammary tumors of BALB/c
mice lacking protein expression of the estrogen receptor
a [12,13]. When injected into the mammary fat pads of
syngeneic BALB/c mice, 4T1 cells grow into solid
tumors that metastasize to the lung, liver, lymph nodes,
and brain, while the primary tumor grows in situ
[14,15]. The 4T1 orthotopic model closely mimics the
progressive forms of estrogen-insensitive human meta-
static breast cancer [16]. Additionally, BALB/c mice are
obesity resistant, and high-fat diet (HFD) consumption
has little effect on body weight [17].
In this study we demonstrated that the prolonged con-
sumption of an HFD without any reduction in the
intake of protein, minerals, vitamins, and fiber has little
effect on energy intake and body weight but does
increase breast cancer growth and metastasis, as well as
mortality in BALB/c mice.
Materials and methods
Materials
Reagents were purchased from the following suppliers:
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide (MTT), Bouin solution, and anti-b-actin antibody
from Sigma (St. Louis, MO, USA); antibodies against
CD45, matrix metalloproteinase (MMP)-9, tissue inhibi-
tor of matrix metalloproteinase (TIMP)-2, intercellular
adhesion molecule (ICAM)-1, and vascular cell adhesion
molecule (VCAM)-1, and enzyme-linked immunosor-
bent assay (ELISA) kits for soluble ICAM-1, macrophage
colony stimulating factor (M-CSF), TIMP-1, leptin, and
triggering receptor expressed on myeloid cells (TREM)-
1 from R and D Systems (Minneapolis, MN, USA);
ELISA kits for complement fragment 5a (C5a) and inter-
leukin (IL)-16 from USCN Life Science and Technology
Company (Missouri City, TX, USA); antibodies against
urokinase-type plasminogen activator (uPA) from Cal-
biochem (La Jolla, CA, USA); antibodies against E2F1,
proliferating cell nuclear antigen (PCNA), p27, cyclin-
dependent kinase (CDK)2, CDK4, cyclin A, cyclin D1,
CD31, and vascular endothelial growth factor (VEGF),
plasminogen activator inhibitor (PAI)-1 from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); antibodies against
Ki67 and F4/80 from Abcam (Cambridge, MA, USA);
horseradish peroxidase-conjugated anti-rabbit, anti-
mouse, and anti-goat IgG from Amersham Biosciences
(Arlington Heights, IL, USA); an antibody against CD68
from ABBIOTEC (San Diego, CA, USA); and Immobilon
Western ChemiluminescentH R PS u b s t r a t ea n da d h e -
sion assay kit from Millipore Corporation (Billerica,
MA, USA). If not otherwise noted, all other materials
were purchased from Sigma-Aldrich Co.
4T1 cell culture
4T1 murine mammary carcinoma cells were acquired
from the American Type Culture Collection (Manassas,
MA, USA) and maintained in Dulbecco’sM o d i f i e d
Eagle’s Medium (DMEM) containing 100 ml/L of fetal
bovine serum (FBS) with 100,000 U/L of penicillin and
100 mg/L of streptomycin in a humidified atmosphere
of 5% CO2 in air.
Animals
Three-week-old female BALB/c mice were purchased
from Orient Bio Inc. (Seongnam, Korea) and housed at
the animal research facility of Hallym University. Mice
were acclimatized to the laboratory conditions and pro-
vided free access to a standard nonpurified rodent diet
(Superfeed Co., Wonju, Korea) and water. The mice were
acclimated for 1 week before use and maintained
throughout the study in a controlled environment: 24 ±
2°C, 50 ± 10% relative humidity, and a 12-hour light/dark
cycle. To determine the survival rate of animals, mice
were killed when they reached moribund conditions, as
described by Toth et al. [18]. All experiments were con-
ducted in accordance with the protocols approved by the
Animal Care and Use Committee of the Hallym Univer-
sity, Korea (Ethical approval number: Hallym 2009-122).
Diets
The mice were randomly divided into two groups; the
control and high-fat groups. The purified diets used in this
study were purchased from Research Diets, Inc. (New
Brunswick, NJ, USA). The control diet (CD; No. D12450B)
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D12451 and D12452) contained 45% and 60% of kcal from
fat. The lard content was 4.4, 39.4, and 54.4 kcal% in the
10, 45, and 60 kcal% diets, respectively. The three diets
contained identical quantities of protein, cellulose, soybean
oil, vitamins, and minerals per kilocalorie (Additional file
1). Fresh diet was freely provided each day, and daily feed
intake was monitored throughout the study.
In vivo mammary cancer orthograft model
Twelve or 16 weeks after initiating feeding, 4T1 cells (5
×1 0
4 cells suspended in 0.1 ml Matrigel(BD Bios-
ciences, San Jose, CA, USA) were injected into the ingu-
inal mammary fat pads of the mice. The mice continued
on their respective diets. In experiment I, the mice were
maintained for 42 days after the 4T1 cell injection to
monitor mammary cancer-related death, and the
Kaplan-Meier curve was plotted for two dietary groups
associated with mouse survival. In experiment II, 25
days after the 4T1 cell injections, the mice were killed
with carbon dioxide asphyxiation, and the tumors,
lungs, livers, kidneys, gonadal fat pads, and spleens were
e x c i s e df r o mt h em i c ea n dw e i g h e d .T h es e r aw e r ep r e -
pared for ELISA.
Tumor volumes were measured with a set of calipers
and calculated by using the following formula: 0.52 ×
long diameter × short diameter
2 [19]. The tumors and
gonadal fat pads were formalin fixed and paraffin
embedded for immunohistochemistry (IHC) or homoge-
nized to prepare the tissue lysates [20] for Western blot
analysis. The lungs and livers were fixed in Bouin solu-
tion or homogenized to prepare the tissue lysates [20].
Metastatic nodules in the lungs and livers were counted,
and the total tumor volumes were estimated as
described previously [21,22].
Immunohistochemistry
Paraffin-embedded tumor tissues were sectioned, depar-
affinized, rehydrated, incubated in 3% H2O2,a n d
blocked with 5% BSA, as previously described [23]. IHC
was conducted with the indicated antibodies, biotiny-
lated rabbit anti-mouse IgG, streptavidin-horseradish
peroxidase, 1,3 -diaminobenzidine (DAB) tetrahy-
drochloride, and hematoxylin, as described previously
[23]. Randomly chosen fields were photographed at
×200 magnification, and immuno-positive cells and
staining intensities were quantified with a Carl Zeiss
AxioImager microscope and Image M1 Software (Carl
Zeiss, Jena, Germany).
Western blot analysis
Western blot analyses were conducted as described pre-
viously [24]. Signals were detected through enhanced
chemiluminescence by using Immobilon Western
Chemiluminescent HRP Substrate (Millipore Corpora-
tion). The relative abundance of each band was quanti-
fied by using the Bio-profile Bio-1D application (Vilber-
Lourmat, Marine la Vallee, France), and the expression
levels were normalized to b-actin.
Mouse cytokine antibody array
Pooled sera from each group were applied to a pro-
teome profiler antibody array kit (R&D Systems) to eval-
uate cytokine expression, in accordance with the
manufacturer’s instructions. The relative abundance of
each protein was quantified by using the Bio-profile Bio-
1D application (Vilber-Lourmat), and the expression
levels were normalized to the control protein.
Enzyme-linked immunosorbent assay
The levels of C5a, sICAM-1, IL-16, M-CSF, TIMP-1,
leptin, and TREM-1 in sera were estimated by using the
relevant ELISA kits according to the manufacturers’
instructions.
Cell-viability assay
4T1 cells were plated in 24-well plates at 5 × 10
4 cells/
well in DMEM supplemented with 100 ml/L FBS. One
day later, the monolayers were serum deprived with
DMEM supplemented with 10 ml/L charcoal-stripped
FBS (serum-deprivation medium) for 24 hours, and the
cells were incubated in serum-deprivation medium in
the absence or presence of various cytokines. Viable cell
numbers were estimated with an MTT assay, as
described previously [25].
In vitro migration assay
The cell-migration assay was conducted as described
previously [26]. Serum-deprived cells were plated onto
the filter in 6.5-mm transwell inserts in 24-well plates at
5×1 0
4 cells/filter and treated for 16 hours with various
cytokines in serum-deprivation medium. Migrated cells
were stained with hematoxylin and eosin (H&E), and
then counted under a light microscope in eight rando-
mized fields.
Adhesion assay
4T1 cells were plated in human collagen type I-coated
CytoMatrix Cell Adhesion Strips at 1 × 10
5 cells. Cells
were incubated in DMEM containing 10 ml/L of char-
coal-stripped FBS with various cytokines at 37°C for 45
minutes. Cells were stained with crystal violet, and the
cell-bound stains were quantified by measuring the
absorbance at 570 nm, as described previously [26].
Statistical analysis
The data were expressed as the mean ± SEM. The sig-
nificance of the difference between groups was evaluated
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sion 9.1 (SAS Institute). Differences were considered sig-
nificant at P < 0.05. The Kaplan-Meier curves were
analyzed with a Log-Rank test to assess the significance
of the differences in the survival rates of the mice.
Results
Prolonged high-fat diet consumption increases mammary
cancer-related mortality in BALB/c mice injected with 4T1
cells
The first study determined mortality rates in 4T1 cell-
injected mice fed HFD (45%). Relative to the mice fed
on the CD (10% kcal as fats), the survival rate was lower
i nt h em i c ef e dH F D( P < 0.001; Figure 1a). In the sub-
sequent study, the mice were fed on a 60% kcal-diet or
the CD for 16 weeks and then injected with 4T1 cells.
Again, survival rates were reduced in the mice fed on
the HFD (60% kcal) as compared with controls (P <
0.001, Figure 1b).
Long-term consumption of a 60% kcal-fat diet increases
solid tumor growth of 4T1 cells in BALB/c mice
Body weights were slightly higher in the mice fed on the
60% kcal-fat diet than in controls from 1 week onward
after initiating experimental diets (Figure 1c). Final body
weights were 24.7 ± 0.3 g and 26.2 ± 0.5 g in the con-
trol and high-fat groups. Energy intakes were only
slightly higher in the high-fat group (Figure 1d). Spleen
and gonadal fat-pad weights were significantly higher in
the HFD-fed mice. However, the weights of the liver,
lung, and kidney were unaffected by prolonged feeding
on the HFD (Table 1). The subcutaneous fat, mesenteric
fat, and retroperitoneal fat were almost undetectable to
the naked eye in the BALB/c mice fed on either the CD
or HFD. The wet weight of the primary solid tumors
was increased by 22.4% (P < 0.0047), and tumor volume,
increased by 28.0% (P < 0.0022) in HFD-fed mice com-
pared with controls (Figure 1e, f).
Long-term consumption of a 60% kcal-fat diet increases
cancer cell proliferation, angiogenesis, and infiltration of
immune cells in 4T1 tumors in BALB/c mice
IHC staining revealed that the HFD-fed mice had signif-
icantly increased expression of Ki67 (P < 0.0084), CDK2
(P < 0.0152), cyclin D1 (P < 0.0381), and cyclin A (P <
0.0284) relative to controls (Figure 2a, b). Western blot-
ting showed that the expression levels of PCNA and
E2F1 were increased by 72.0% (P < 0.017) and 90.0% (P
< 0.05), respectively, in the tumor tissues of HFD-fed
mice relative to controls. In contrast, p27 (Kip1) expres-
sion was reduced significantly in the HFD-fed mice (Fig-
ure 2c).
IHC staining showed that the expressions of CD31,
VEGF, CD68, and CD45 were markedly increased in the
tumors of the HFD-fed mice compared with controls
(Figure 3a,b). H&E staining showed that the number of
lipid vacuoles increased in the tumor tissues of the
HFD-fed mice (Figure 3a, b). The number of F4/80+
cells was significantly increased in the gonadal fat pads
of mice fed on the HFD (Figure 3c).
Prolonged consumption of a 60% kcal-fat diet increases
lung and liver metastasis of 4T1 cells in BALB/c mice
Tumor nodules grew in all mice in both groups, but in
HFD-fed mice, the number and volume of tumor
nodules on the lung increased by 65.2% (P < 0.0298)
and 159.9% (P < 0.05), respectively, as compared with
t h em i c ef e do nt h eC D( F i g u r e4 a - c ) .I nt h el i v e r ,t h e
incidence of tumor nodules was 35.7% and 66.7% in the
CD group and HFD groups, respectively; and the num-
ber of nodules was 844% (P < 0.0159) greater in the
HFD-fed mice. Additionally, long-term consumption of
t h eH F Dr e s u l t e di na1 , 5 6 8 %( P < 0.0188) increase in
the volume of tumor nodules in the liver as compared
with controls (Figure 4d-f).
A 60% kcal-fat diet alters the expression of proteins
involved in metastasis in the lungs of BALB/c mice
injected with 4T1 cells
Western blot analysis of lung tissue lysates revealed that
HFD increased the protein levels of uPA, ICAM-1, and
VCAM-1 in the lungs by 98.0% (P < 0.0089), 89.0% (P <
0.008), and 63.0% (P < 0.0069), respectively, as com-
pared with control mice, whereas a significant (P < 0.05)
reduction of PAI-1 expression was noted in the mice
fed HFD (Figure 5).
A 60% kcal-fat diet increases serum levels of C5a, sICAM-
1, IL-16, M-CSF, TIMP-1, leptin, and TREM-1 in BALB/c
mice injected with 4T1 cells
Because a variety of cytokines are known to affect the
processes of breast cancer growth and metastasis
(reviewed in [27]), the serum cytokines levels were esti-
mated by using a mouse cytokine antibody array kit.
Among the 40 cytokines measurable with the mouse
cytokine array kit, seven cytokines (C5a, sICAM-1, IL-
1 6 ,G - C S F ,M - C S F ,T I M P - 1 ,a n dT R E M - 1 )w e r e
detected in the sera of mice. The levels of C5a, sICAM-
1, IL-16, M-CSF, TIMP-1, and TREM-1 were increased
i nt h es e r ao ft h eH F D - f e dm i c er e l a t i v et ot h o s eo ft h e
controls, whereas the level of granulocyte colony-stimu-
lating factor (G-CSF) was not altered (data not shown).
We subsequently confirmed the results with ELISA and
noted changes similar to those observed in the antibody
array. HFD increased serum levels of C5a, sICAM-1, IL-
16, M-CSF, TIMP-1, and TREM-1 by 31.8% (P <0 . 0 5 ) ,
31.8% (P < 0.0002), 26.0% (P < 0.002), 61.0% (P <
0.0001), 40.9% (P < 0.0032), and 41.3% (P <0 . 0 0 2 ) ,
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Page 4 of 13Figure 1 A high-fat diet reduces the survival rate and increases solid tumor growth in BALB/c mice injected with 4T1 cells. (a) Four-
week-old, female BALB/c mice were fed on a high-fat diet in which 45% of the kilocalories were provided as fats or a control diet in which 10%
of kilocalories were provided as fats for 12 weeks. Twelve weeks after initiating feeding, 4T1 cells (5 × 10
4 cells suspended in 0.1 ml gelatinous
protein (Matrigel) were injected into the inguinal mammary fat pads of the mice. The mice were fed continuously on the same diets. Survival
rates were monitored after the 4T1 cell injection (0 day). (b) Four-week-old, female BALB/c mice were fed on a high-fat diet in which 60% of the
kilocalories were provided as fats or the control diet (10% kcal fat) for 16 weeks. Sixteen weeks after the initiation of feeding, 4T1 cells were
injected, and mice were continuously fed on the same diet. (c-f) Mice were fed on the diets and injected with 4T1 cells, as described in b,
except that they were killed 25 days after the 4T1 cells injection. (c) Body weights of mice were measured every week. Each point of body
weight represents the mean ± SEM (n = 30). (d) Energy intake was calculated on the basis of 16.12 kJ/g in the control diet and 21.93 kJ/g in the
high-fat diet. Each point of energy intake represents the mean ± SEM (n = 6). *Significantly different from the control group, P < 0.05. (e) The
tumors were excised from mice and weighed. (f) The tumor volume was measured by using calipers and calculated with the formula: 0.52 ×
long diameter × short diameter
2. Each bar represents the mean ± SEM (n = 30). *Significantly different from the control group, P < 0.05.
Kim et al. Breast Cancer Research 2011, 13:R78
http://breast-cancer-research.com/content/13/4/R78
Page 5 of 13respectively, relative to control mice. HFD also increased
the serum levels of leptin by 36.0% (P < 0.0013) relative
to controls (Table 2).
Various cytokines elevated by HFD increased the viability,
adhesion, and migration of 4T1 cells in vitro
We next conducted in vitro assays to determine the
effects of the cytokines that were elevated in vivo by
HFD on the viability, adhesion, and migration of 4T1
cells. The concentrations of cytokines used in these
assays were the mean concentrations detected in the
sera of the HFD-fed mice (Table 2). Among these cyto-
kines, only sICAM-1 enhanced the viability of 4T1 cells
(Figure 6a). The capacity of the 4T1 cells to adhere to
strips coated with human collagen type I was increased
by C5a, sICAM-1, IL-16, M-CSF, TIMP-1, and TREM-1
(Figure 6b). Additionally, TREM-1, TIMP-1, M-CSF,
and sICAM-1 significantly increased the migration of
4T1 cells (Figure 6c).
Discussion
The principal objective of this study was to determine
whether dietary fat increases mammary tumor growth
a n dm e t a s t a s i sa sw e l la sm a mmary cancer-associated
mortality in obesity-resistant BALB/c mice. BALB/c
mice fed on the 60% kcal-fat diet consumed less food,
such that their intake of protein, vitamins, minerals,
fiber, and kilocalories was only slightly increased rela-
tive to that of the control mice. Epidemiologic evi-
dence indicates that the consumption of fiber,
vegetable, and micronutrients is associated with
reduced mortality in postmenopausal women diag-
nosed with breast cancer [28]. Other previous findings
also suggested the possible benefits of a low-fat/high-
vegetable diet on disease-free survival (reviewed in
[29]). The present results clearly show that increased
dietary fat intake, without decreasing other nutrients
(except for carbohydrates) and with little effect on
energy intake and weight, increases mammary cancer
growth, angiogenesis, metastasis, and mortality of
BALB/c mice with implanted tumors.
Xu et al.[ 3 0 ]d e m o n s t r a t e dt h a tav a r i e t yo fi n f l a m -
matory and macrophage-specific genes are upregulated
dramatically in white adipose tissues of C57BL/6J mice
fed a 60% kcal diet for 16 weeks. Their control and
high-fat diets were probably similar to those used in this
study because they were supplied by the same manufac-
turer. Thus, in the current study, before the injection of
4T1 mammary cancer cells, obesity-resistant BALB/c
mice were fed a 60% kcal-fat diet for 16 weeks to induce
chronic low-grade inflammation. We noted that the
body weights were only slightly increased in the BALB/c
mice fed on the HFD. At the end of the experiment, the
change in body weight due to the long-term high-fat
feeding was measured at only 4% after correction for
differences in tumor and spleen weights. At autopsy, we
were unable to detect visible adipose tissues except in
the gonadal fat pad, the weight of which was increased
in the HFD-fed mice. These results contrast markedly
from those reported by Xu et al. [30], who demon-
strated that HFD markedly increased the body weights
of C57BL/6J mice. This discrepancy between the results
was anticipated, however, because C57BL/6 mice are
obesity susceptible, and BALB / cm i c ea r eo b e s i t yr e s i s -
tant [17]. Macrophage accumulation was noted in the
adipose tissues of C57BL/6J mice fed on an HFD [31].
In this study, we noted that F4/80+ macrophage infiltra-
tion in the gonadal fat pad and the serum levels of cyto-
kines (C5a, sICAM-1, IL-16, M-CSF, TIMP-1, and
TREM-1) were elevated in HFD-fed mice (Table 2).
These results indicate that dietary fat induces a low-
g r a d ei n f l a m m a t i o ni nt h ea b s e n c eo fo b e s i t y ,a n da
small increase in adipose tissue may have contributed to
the induction of inflammation.
Leptin is a cytokine-like protein secreted from adipose
tissue [32], and circulating leptin levels are positively asso-
ciated with body weight and/or body fat [33,34]. Leptin
and leptin receptor are involved in the development of
normal mammary glands and in the progression of breast
cancer [35-37]. In this study, we found that the serum
levels of leptin were elevated in HFD-fed mice without a
discernible change in body weight, indicating that a small
increase in fat mass increases serum leptin levels, and the
elevated leptin may have contributed to the stimulation of
mammary cancer progression in these mice.
The increased expression of CD31 and VEGF in
tumor tissues (Figure 3a) indicates that tumor angiogen-
esis increased in the HFD-fed mice. Recent evidence
indicates that in addition to the interactions of cancer
cells and endothelial cells, inflammatory cells also play
an important role in the formation of the blood vessels
that nourish a growing tumor (reviewed in [38]).
Tumor-associated immune cells, including macrophages,
Table 1 Effect of chronic consumption of a high-fat diet
on organ weights in BALB/c mice injected with 4T1 cells
Control diet High-fat diet
Liver (g) 1.34 ± 0.02 1.35 ± 0.03
Lung (g) 0.28 ± 0.01 0.30 ± 0.01
Kidney, right (g) 0.16 ± 0.01 0.16 ± 0.01
Kidney, left (g) 0.16 ± 0.01 0.16 ± 0.01
Spleen (g) 0.81 ± 0.04 1.02 ± 0.04
a
Gonadal fat pad (g) 0.19 ± 0.02 0.25 ± 0.04
a
Mice were fed on the high-fat (60% kcal) or control diet (10% kcal) for 16
weeks and injected with 4T1 cells, as described in Materials and Methods.
Twenty-five days after the injection of 4T1 cells, the mice were killed, and the
lungs, livers, kidneys, spleens, and gonadal fat pads were excised from the
mice and weighed. Values represent the means ± SEM (n = 30).
aSignificantly
different from the control group, P < 0.05.
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late tumor angiogenesis (reviewed in [39]). Additionally,
a significant positive correlation between the degree of
angiogenesis and the number of CD68+ cells has been
demonstrated in human breast carcinoma [40]. The
number of CD45+ and CD68+ cells was markedly
increased in the tumor tissues of HFD-fed mice (Figure
3a), indicating increased infiltration of these immune
cells into tumor tissues, which possibly increased tumor
angiogenesis.
In this study, we noted that blood levels of various
cytokines were increased in the HFD-fed mice (Table 2).
Figure 2 Dietary fat stimulates cell-cycle progression in 4T1 tumors in BALB/c mice. Mice were fed, injected with 4T1 cells, and then killed
as described in Figure 1c. (a) Tumor sections were stained with antibody raised against Ki67, cyclin-dependent kinase (CDK)2, CDK4, cyclin D1, or
cyclin A, and then with 1,3 -diaminobenzidine (DAB) and counterstained with hematoxylin (n = 15). Representative images of the
immunohistochemical analysis are shown. (b) The Ki67-, CDK2-, CDK4-, cyclin D1-, and cyclin A-positive cells were counted. Each bar represents
the means ± SEM (n = 15). (c) Tumor lysates were analyzed with Western blotting with the indicated antibodies. Photographs of
chemiluminescent detection of the blots are shown. The relative abundance of each band to its own b-actin was quantified, and the control
levels were at 100%. The adjusted mean ± SEM is shown above each blot. *Significantly different from the control group, P < 0.05. PCNA,
proliferating cell nuclear antigen.
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Page 7 of 13Figure 3 Dietary fat stimulates angiogenesis and immune cell infiltration in 4T1 tumors and macrophage infiltration in the gonadal
fat pad in BALB/c mice. Mice were fed, injected with 4T1 cells, and then killed as described in Figure 1c. (a) Tumor sections were stained with
antibody raised against CD31, vascular endothelial growth factor (VEGF), CD45, or CD68, and then with 1,3 -diaminobenzidine (DAB), and
counterstained with hematoxylin, except that the last one was stained with hematoxylin and eosin (H&E) to visualize lipid vacuoles.
Representative images of the immuno-histochemical analysis and H&E staining are shown, n = 15. (b) The staining intensity of CD31 and VEGF
was quantified. CD45+ and CD68+ cells and the number of lipid vacuoles were counted. Each bar represents the mean ± SEM (n = 15). (c)
Gonadal fat-pad sections were stained with an F4/80 antibody, and F4/80+ cells were counted, n = 15. Each bar represents the mean ± SEM (n
= 15).*Significantly different from the control group, P < 0.05.
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Page 8 of 13Figure 4 Dietary fat stimulates the lung and liver metastasis of 4T1 cells in BALB/c mice. Mice were fed, injected with 4T1 cells, and then
killed as described in Figure 1c. The lungs and livers were excised from mice and fixed in Bouin solution. The numbers of tumor nodules in the
lung and liver was counted, and the total tumor volumes were estimated. (a, d) Photographs of the lungs and livers, which were representative
of 15 animals, are shown. Whitish tumor lesions can be observed on the surfaces of the lungs and livers. (b, e) The numbers of tumor nodules
in the lung and liver. (c, f) The volume of tumor nodules in the lung and liver. Each bar represents the mean ± SEM (n = 15). *Significantly
different from the control group, P < 0.05.
Kim et al. Breast Cancer Research 2011, 13:R78
http://breast-cancer-research.com/content/13/4/R78
Page 9 of 13Our in vitro studies demonstrated that some of these
cytokines stimulated the growth, migration, and adhe-
sion of 4T1 mammary cancer cells (Figure 6). These
results indicate that the increased cytokine levels may
have contributed to changes in the expression of metas-
tasis-related proteins (uPA, ICAM-1, and VCAM-1),
thereby increasing metastasis. Future studies are needed
to determine which types of cells secrete these cytokines
in tumors, adipose tissues, the lungs, and/or the liver.
It was previously reported that adipocytes promote
breast carcinoma cell growth in collagen gels by the
cancer-stromal interaction [41]. Additionally, when co-
injected with SUM159PT mammary adenocarcinoma
cells in athymic nude mice, fully differentiated 3T3-L1
adipocytes stimulate tumor growth and lung metastasis
[42]. We observed increased numbers of lipid vacuoles
in the tumor tissues of HFD-fed mice (Figure 3a). Along
with the tumor cells, these adipocytes may participate in
the recruitment of immune cells into the tumor. The
crosstalk between tumor cells, adipocytes, and immune
cells within the tumors of the HFD-fed mice (Figure 3a)
m a yh a v ep r o d u c e dab r o a dv a r i e t yo fg r o w t hf a c t o r s ,
cytokines, and chemokines, resulting in changes in the
expression of proteins involved in the stimulation of
cell-cycle progression of tumor cells (Ki67, PCNA,
CDK2, CDK4, cyclin A, and cyclin D) and angiogenesis
(VEGF) (Figure 2a-c, 3a). Additionally, the increase in
new blood vessels may have supplied nutrients and
growth factors for the stimulation of cell-cycle progres-
sion in addition to the stimulation of metastasis. In this
study, the direct mechanism by which HFD feeding
induces the expression of metastasis-regulating proteins,
cyclins, and CDKs in the tumor tissues was not fully
elucidated.
In this study, we noted that the weights of spleen were
increased in the HFD-fed mice (Table 1), which was
accompanied by increases in the serum levels of C5a,
IL-16, sICAM-1, M-CSF, TIMP-1, TREM-1, and leptin
(Table 2). Splenomegaly was invariably observed in 4T1-
tumor-bearing mice [43-45], and correlated strongly
with increased extramedullary hematogenesis and
metastasis in the spleen and circulating levels of neutro-
phils and leukocytes [46]. It has been reported that 4T1
tumor growth is associated with increased splenomegaly
or splenomegaly-associated inflammation, and various
tumor-derived cytokines, such as G-CSF, GM-CSF, and
IFN-g, may be responsible for the splenomegaly in mice
injected with 4T1 cells [44]. Future studies are needed
to determine whether the increases in C5a, IL-16,
sICAM-1, M-CSF, TIMP-1, TREM-1, and/or leptin are
responsible for the increased splenic mass in HFD-fed
mice.
Figure 5 Dietary fat alters the protein levels of urokinase-type
plasminogen activator (uPA), plasminogen activator inhibitor
(PAI)-1, intercellular adhesion molecule (ICAM)-1, and vascular
cell adhesion molecule (VCAM)-1 in the lungs of BALB/c mice
injected with 4T1 cells. Mice were fed, injected with 4T1 cells, and
then killed as described in Figure 1c. Lung lysates were analyzed
with Western blotting with the indicated antibodies. Photographs of
chemiluminescent detection of the blots are shown. The relative
abundance of each band to its own b-actin was quantified, and the
control levels were set at 100%. The adjusted mean ± SEM is shown
above each blot. *Significantly different from the control group, P <
0.05. MMP, matrix metalloproteinase; TIMP, tissue inhibitor of matrix
metalloproteinase.
Table 2 Effect of prolonged consumption of a high-fat
diet on the levels of various cytokines in the sera of
BALB/c mice injected with 4T1 cells
Control diet High-fat diet
C5a (ng/ml) 22.0 ± 2.7 29.0 ± 3.1
a
sICAM-1 (ng/ml) 494.2 ± 22.6 651.5 ± 29.4
a
IL-16 (ng/ml) 150.8 ± 8.0 190.0 ± 8.4
a
M-CSF (pg/ml) 714.1 ± 29.3 1,149.5 ± 35.6
a
TIMP-1 (ng/ml) 4.4 ± 0.4 6.2 ± 0.4
a
TREM-1 (pg/ml) 684.7 ± 17.8 967.8 ± 21.6
a
Leptin (ng/ml) 138.0 ± 0.04 187.8 ± 11.3
a
Mice were fed on the high-fat (60% kcal) or control diet (10% kcal) for 16
weeks and injected with 4T1 cells, as described in Materials and Methods. At
25 days after the 4T1 cells injection, blood samples were collected from the
mice, and the sera were prepared. The serum levels of complement fragment
5a (C5a), soluble intercellular adhesion molecule (sICAM)-1, interleukin (IL)-16,
macrophage colony-stimulating factor (M-CSF), tissue inhibitor of matrix
metalloproteinase (TIMP)-1, triggering receptor expressed on myeloid cells
(TREM)-1, and leptin were measured with the appropriate ELISA kits. Values
represent the mean ± SEM (n = 30).
aSignificantly different from the control
group, P < 0.05.
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Page 10 of 13Figure 6 Effect of various cytokines on proliferation (a), adhesion (b), and migration (c) of 4T1 cells in vitro. (a) 4T1 cells were plated in
24-well plates at 5 × 10
4 cells/well in DMEM supplemented with 100 ml/L FBS. One day later, the monolayers were serum deprived with DMEM
supplemented with 10 ml/L charcoal-stripped FBS (serum-deprivation medium) for 24 h. After serum deprivation, the cells were incubated in
serum-deprivation medium in the absence or presence of 29 ng/ml complement fragment 5a (C5a), 652 ng/ml soluble intercellular adhesion
molecule (sICAM)-1, 190 ng/ml interleukin (IL)-16, 1,150 pg/ml macrophage colony-stimulating factor (M-CSF), 6.2 ng/ml tissue inhibitor of matrix
metalloproteinase (TIMP)-1, and 970 pg/ml triggering receptor expressed on myeloid cells (TREM)-1 for 24 hours. Viable cell numbers were
estimated. Each bar represents the mean ± SEM (n = 3). Means without a common letter differ, P < 0.05. (b) Cells were plated in human
collagen type I-coated CytoMatrix Cell Adhesion Strips and incubated with or without various cytokines (the identical concentrations of cytokines
used in Figure 6a) in DMEM containing 10 ml/L charcoal-stripped FBS at 37°C for 45 min. The cells were stained with crystal violet, and the cell-
bound stains were quantified by determining the absorbance at 570 nm. Each bar represents the mean ± SEM (n = 7). Means without a
common letter differ, P < 0.05. (c) Cells were serum deprived in DMEM supplemented with 10 ml/L charcoal-stripped FBS for 24 hours. Serum-
deprived cells were plated onto the filter in 6.5-mm transwell inserts in 24-well plates at 5 × 10
4 cells/filter. Before the plating of the cells, the
lower side of the transwell filter was precoated with type IV collagen. The lower chamber of the well was filled with DMEM containing 100 ml/L
gelatinase-free charcoal-stripped FBS with or without various cytokines (the identical concentrations of cytokines used in Figure 6a). The cells
were incubated for 16 hours. Migrated cells were stained with hematoxylin and eosin. Each bar represents the mean ± SEM (n = 3). Means
without a common letter differ, P < 0.05.
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Page 11 of 13Conclusions
This study clearly demonstrated that dietary fat
increases mammary cancer growth, metastasis, and
mammary cancer-associated mortality in obesity-resis-
tant mice. We also demonstrated that dietary fat
increases the expression of proteins (Ki67, CDKs, and
cyclins) involved in the regulation of cell-cycle progres-
sion as well as increases in the expression of CD31,
VEGF, CD68, and CD45 in tumor tissues, thereby indi-
cating that increases in immune cell infiltration and
angiogenesis stimulate cell-cycle progression and the
metastasis of tumor cells. Additionally, increases in pro-
tease (uPA) and adhesion molecules (ICAM-1, VACM)
may contribute to lung metastasis in HFD-fed mice.
Furthermore, increases in the serum levels of cytokines
may stimulate mammary cancer metastasis in HFD-fed
mice. Our results suggest that dietary fat may increase
breast cancer progression, even in individuals who
maintain a healthy body weight, and that replacing diet-
ary fat with carbohydrates may delay the progression of
breast cancer, thereby reducing breast cancer-associated
mortality.
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